University of Kentucky’s cardiovascular scientist recognized for excellence in hypertension research

The University of Kentucky’s Vice President for Research and leading cardiovascular scientist is being recognized for her foundational work in the field of hypertension with a prestigious award from the American Heart Association (AHA).

FDA offers more guidance on relying on just one trial and confirmatory evidence for a new drug approval

Although FDA isn’t changing what it requires for a new drug to win approval (that hasn’t changed since 1998), the agency on Monday released new

September 19, 2023

Transforming care for rheumatoid arthritis patients through symptom monitoring

Researchers at The University of Manchester are to trial a system that allows people living with rheumatoid arthritis to send their daily symptoms securely to

June 22, 2024

J&J clinches EC approval for first single-pill PAH combo – Pharmaceutical Technology

The European Commission has approved Johnson and Johnson’s Yuvanci for pulmonary arterial hypertension, offering the first single-pill treatment option to European patients. Credit: andreswd via

September 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.